Overexpression of CC3/TIP30 is associated with HER-2/neu status in breast cancer

Journal of Cancer Research and Clinical Oncology

Volumn 131, Issue 9, 2005, Pages 603-608

  Zhang, Dao Hai ^a   Wong, Lee Lee ^b   Tai, Lee Kian ^b   Koay, Evelyn S C ^b   Hewitt, Robert E ^b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Breast cancer; CC3 TIP30; HER 2 neu; Metastasis suppressor

Indexed keywords

ARTICLE; BREAST CANCER; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS INHIBITION; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACETYLTRANSFERASES; AMINO ACID SEQUENCE; BREAST NEOPLASMS; CYTOPLASM; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEIN ARRAY ANALYSIS; RECEPTOR, ERBB-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 27644441369     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-005-0674-z     Document Type: Article

References (17)

1. Baker ME, Yan L, Pear MR (2000) Three-dimensional model of human TIP30, a coactivator for HIV-1 Tat-activated transcription, and CC3, a protein associated with metastasis suppression. Cell Mol Life Sci 57:851-858
2. Hays DF, Thor AD (2002) c-erbB-2 in breast cancer: development of a clinically useful marker. Semin Oncol 29:231-245
3. Hewitt RE, Brown KE, Corcoran ML, Stetler-Stevenson WG (2000) Increased expression of tissue inhibitor of metalloproteinases type I (TIMP-I) in a more tumorigenic colon cancer cell line. J Path 192:455-459
4. Ito M, Jiang C, Krumm K, Zhang X, Pecha J, Zhao J, Guo Y, Roeder RG, Xiao H (2003) TIP30 deficiency increases susceptibility to tumorigenesis. Cancer Res 63:8763-8767
5. Jiang C, Ito M, Piening V, Bruck K, Roeder RG, Xiao H (2004) TIP30 interacts with an estrogen receptor α-interacting coactivator CIA and regulated c-myc transcription. J Biol Chem 279:27781-27789
6. King FW, Shtivelman E (2004) Inhibition of nuclear import by the proapoptotic protein CC3. Mol Cell Biol 24:7091-7101
7. Liu Y, Thor A, Shtivelman E, Cao Y, Tu G, Heath TD, Debs RJ (1999) Systemic gene delivery expands the repertoire of effective antiangiogenic agents sensitizing cell to apoptosis. J Biol Chem 274:13338-13344
8. NicAmhlaoibh R, Shtivelman E (2001) Metastasis suppressor CC3 inhibits angiogenic properties of tumor cells in vitro. Oncogene 20:270-275
9. Schlessinger J (2000) Cell signaling by receptor tyrosine kinases. Cell 103:211-225
10. Shtivelman E (1997) A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma. Oncogene 14:2167-2173
11. Tsutsui S, Ohno S, Murakami S, Hachitanda Y, Odar S (2002) Prognostic value of c-erbB2 expression in breast cancer. J Surg Oncol 79:216-223
12. Whitman S, Wang X, Shalaby R, Shtivelman E (2000) Alternatively spliced products CC3 and TC3 have opposing effects on apoptosis. Mol Cell Biol 20:583-593
13. Xiao H, Tao Y, Greenblatt J, Roeder RG (1998) A cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcription. Proc Natl Acad Sci USA 95:2146-2151
14. Xiao H, Palhan V, Yang Y, Roeder RG (2000) TIP30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genes. EMBO J 19:956-963
15. Yarden Y (2001) Biology of HER2 and its importance in breast cancer. Oncology 61(suppl 2):1-13
16. Zhang D-H, Salto-Tellez M, Do E, Putti TC, Koay ESC (2003a) Evaluation of HER-2/neu oncogene status in breast tumors on tissue microarrays. Hum Pathol 34:362-368
17. Zhang D-H, Salto-Tellez M, Putti TC, Do E, Koay ESC (2003b) Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer. Mod Path 16:79-85